InsidersTradesSigma
Track the 恩华药业 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 恩华药业 has recorded 2 public disclosures. Market capitalisation: €21.8bn. The latest transaction was filed on 22 April 2026 (Purchase). Among the most active insiders: 孙彭生. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恩华药业是一家专注于健康和制药领域的公司，提供一系列医药产品。该公司在XSHE市场上市。